SBP solbec pharmaceuticals limited

fda grants orphan drug to coramsine, page-2

  1. skint
    5,995 Posts.
    lightbulb Created with Sketch. 162
    clock Created with Sketch.
    11/11/05
    12:40
    Post #: 1219547
    This is great news for Solbec, the renal cell carcinoma patient fron the Phase 1 trial with the 15 month ongoing response I guess was a compelling reason to grant orphan drug. It means total protection from competition in the US for coramsine on renal cell cancer.
    SBP Price at posting: 0.0¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Exploration drilling confirms large gold system at Abercromby Gold Project
right-arrow Created with Sketch.
NEWS Agreement to acquire 50% of the Central Tanami Gold Project
right-arrow Created with Sketch.
NEWS Anson Progresses POSCO Due Diligence with Bulk Green River Brine Shipment to Korea
right-arrow Created with Sketch.
NEWS Thick zone of high-grade gold mineralisation intersected at Fairview South
right-arrow Created with Sketch.
NEWS Nyrada advances to final cohort in Phase I clinical trial of Xolatryp
right-arrow Created with Sketch.
NEWS Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.